RF
TEVA icon

Rossby Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Rossby Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$678 Sell
20
-69
-78% -$2.3K ﹤0.01% 1976
2026
Q1 		$2.69K Buy
89
+69
+345% +$2.22K ﹤0.01% 1729
2025
Q4 		$624 Hold
20
– – ﹤0.01% 1601
2025
Q3 		$401 Hold
20
– – ﹤0.01% 1392
2025
Q2 		$335 Hold
20
– – ﹤0.01% 1203
2025
Q1 		$297 Buy
+20
New +$357 ﹤0.01% 1049

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Rossby Financial's TEVA Position: Q2 2026 in Review

Rossby Financial reduced its Teva Pharmaceuticals (TEVA) stake by 78% in Q2 2026, selling an estimated $2.3K and leaving 20 shares worth $678. The position accounts for ﹤0.01% of the portfolio, ranked #1976.

Rossby Financial first reported a position in TEVA in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.69K in Q1 2026. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Rossby Financial held 20 shares of Teva Pharmaceuticals worth $678 as of Q2 2026.
  • Rossby Financial sold 69 Teva Pharmaceuticals shares in Q2 2026, an estimated $2.3K.
  • Teva Pharmaceuticals made up ﹤0.01% of Rossby Financial's portfolio in Q2 2026, its #1976 holding.
  • Rossby Financial first reported a position in Teva Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Rossby Financial's Teva Pharmaceuticals position peaked at $2.69K in Q1 2026.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.